Delivery Order SPE2DB22D2218-SPE2DB24FR2BF
Award Date
2/16/24
Potential Completion Date
2/20/24
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,084.92, and has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $16,992.22, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,726.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $19,855.67, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 25 MCG/0.5 ML TYPHIM VI syringes. The order, valued at $9,263.54, has a completion date of February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. The contract has a ceiling value of $25,057.40 and a period of performance through May 23, 2025. This award is not set-aside and represents an open competition. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $8,592.90 and is a Firm Fixed Price Delivery Order with an ultimate completion date of December 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen also holds a...
This federal contract award, valued at $3,421.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a performance period through April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, under a firm fixed price delivery order. The contract has a ceiling value of $5,770.10 and a period of performance through March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not...